Drug Type Diagnostic radiopharmaceuticals |
Synonyms [18F] MIPS15692, [18F]-MIPS15692, [18F]MIPS15692 |
Target |
Action inhibitors |
Mechanism MerTK inhibitors(Tyrosine-protein kinase Mer inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuroinflammation | Preclinical | Australia | 15 Dec 2021 |





